Literature DB >> 11277727

Getting discriminant functions of antibacterial activity from physicochemical and topological parameters.

R K Mishra1, R Garcia-Domenech, J Galvez.   

Abstract

Linear discriminant analysis has been demonstrated to be a very useful tool in the selection and design of new drugs. Up to now we have used it through the search of a topological pattern of activity. In this work our goal is to calculate a complete set of physicochemical parameters using semiempirical (quantum chemical) calculations as well as topological indices (TIs) and try to find out any discriminant function for antibacterial activity through the combined use of both types of descriptors. The physicochemical parameters, such as heat of formation, HOMO, LUMO, dipole moment, polarizability, hyperpolarizability, PM3 generated IR vibrational frequencies, etc., were calculated using PM3 Hamiltonian implemented within the MOPAC97 package. Among the TIs, connectivity as well as topological charge indices stands as the most representatives. The obtained results suggest that one of the maxima and minima vibrational frequencies play an important role in the antibacterial activity. These frequencies are associated with the torsional molecular vibration (N3) and the stretching vibration (N5) of X-H groups (X = C, N, O). Furthermore, the differences between the maxima and minima values showed an even better discriminant ability than the values themselves. The additional use of the topological indices provided a clear improvement in the discriminant function and also provided a straightforward way to predict the values of such frequencies, so that the results can be applied to a large set of compounds searching for new candidates as antibacterials.

Mesh:

Substances:

Year:  2001        PMID: 11277727     DOI: 10.1021/ci000303c

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  7 in total

1.  Non-stochastic and stochastic linear indices of the molecular pseudograph's atom-adjacency matrix: a novel approach for computational in silico screening and "rational" selection of new lead antibacterial agents.

Authors:  Yovani Marrero-Ponce; Ricardo Medina Marrero; Francisco Torrens; Yamile Martinez; Milagros García Bernal; Vicente Romero Zaldivar; Eduardo A Castro; Ricardo Grau Abalo
Journal:  J Mol Model       Date:  2005-11-04       Impact factor: 1.810

2.  Application of 'inductive' QSAR descriptors for quantification of antibacterial activity of cationic polypeptides.

Authors:  Artem Cherkasov; Bojana Jankovic
Journal:  Molecules       Date:  2004-12-31       Impact factor: 4.411

3.  Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer-aided molecular design III: 2.5D indices for the discovery of antibacterials.

Authors:  Humberto González-Díaz; Luis A Torres-Gómez; Yaima Guevara; Manuel S Almeida; Reinaldo Molina; Nilo Castañedo; Lourdes Santana; Eugenio Uriarte
Journal:  J Mol Model       Date:  2005-02-19       Impact factor: 1.810

4.  Synthesis and Biological Evaluation of Muraymycin Analogues Active against Anti-Drug-Resistant Bacteria.

Authors:  Tetsuya Tanino; Satoshi Ichikawa; Bayan Al-Dabbagh; Ahmed Bouhss; Hiroshi Oyama; Akira Matsuda
Journal:  ACS Med Chem Lett       Date:  2010-06-02       Impact factor: 4.345

5.  Topological virtual screening: a way to find new compounds active in ulcerative colitis by inhibiting NF-κB.

Authors:  María Gálvez-Llompart; María C Recio; Ramón García-Domenech
Journal:  Mol Divers       Date:  2011-06-30       Impact factor: 2.943

6.  New active drugs against liver stages of Plasmodium predicted by molecular topology.

Authors:  Nassira Mahmoudi; Ramon Garcia-Domenech; Jorge Galvez; Khemais Farhati; Jean-François Franetich; Robert Sauerwein; Laurent Hannoun; Francis Derouin; Martin Danis; Dominique Mazier
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

7.  Identification of Novel Antibacterials Using Machine Learning Techniques.

Authors:  Yan A Ivanenkov; Alex Zhavoronkov; Renat S Yamidanov; Ilya A Osterman; Petr V Sergiev; Vladimir A Aladinskiy; Anastasia V Aladinskaya; Victor A Terentiev; Mark S Veselov; Andrey A Ayginin; Victor G Kartsev; Dmitry A Skvortsov; Alexey V Chemeris; Alexey Kh Baimiev; Alina A Sofronova; Alexander S Malyshev; Gleb I Filkov; Dmitry S Bezrukov; Bogdan A Zagribelnyy; Evgeny O Putin; Maria M Puchinina; Olga A Dontsova
Journal:  Front Pharmacol       Date:  2019-08-27       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.